Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RIVCO AUSTRALIA LTD Capital/Financing Update 2018

Jan 14, 2018

65706_rns_2018-01-14_c2710d13-dab2-4799-894a-d6888c246954.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [96 x 115] intentionally omitted <==

ANNOUNCEMENT TO AUSTRALIAN SECURITIES EXCHANGE

15 January 2018

ASX Limited Companies Announcement Office Electronic Lodgement System

Dear Sirs

Section 708A Notice – Shares Issued on Conversion of Options

Duxton Water Limited (Company) hereby provides notice to the ASX for the purpose of section 708A(5)(e) of the Corporations Act 2001 (Cth) that it has issued 30,000 fully paid ordinary shares in the Company (Shares) without disclosure to investors under Part 6D.2 of the Corporations Act 2001 (Cth).

The Company states that as at the date of this notice it:

  • has complied with the provisions of Chapter 2M of the Corporations Act 2001 (Cth) as they apply to the Company;

  • has complied with section 674 of the Corporations Act 2001 (Cth); and

  • is not aware of any excluded information within the meaning of sections 708A(7) and 708A(8) of the Corporations Act (Cth).

An Appendix 3B relating to this issue is attached to this announcement.

Yours Faithfully

==> picture [150 x 39] intentionally omitted <==

Donald Stephens Company Secretary

Duxton Water Limited 7 Pomona Road, Stirling SA 5152 www.duxtonwater.com.au

Rule 2.7, 3.10.3, 3.10.4, 3.10.5

Appendix 3B

New issue announcement, application for quotation of additional securities and agreement

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13

Name of entity

Duxton Water Limited

ABN

53 611 976 517

We (the entity) give ASX the following information.

Part 1 - All issues

You must complete the relevant sections (attach sheets if there is not enough space).

1 +Class of +securities issued Fully Paid Ordinary Shares or to be issued 2 Number of +securities 30,000 (thirty thousand) issued or to be issued (if known) or maximum number which may be issued

  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 1

3
Principal
terms
of
the
+securities (e.g. if options,
exercise price and expiry
date;
if
partly
paid
+securities,
the
amount
outstanding and due dates
for payment; if+convertible
securities, the conversion
price
and
dates
for
conversion)
4
Do
the
+securities rank
equally in all respects from
the+issue date with an
existing+class of quoted
+securities?
If the additional+securities
do not rank equally, please
state:
 the date from which they
do
 the extent to which they
participate for the next
dividend, (in the case of
a trust, distribution) or
interest payment
 the extent to which they
do
not
rank
equally,
other than in relation to
the
next
dividend,
distribution or interest
payment
Same terms as ordinary shares –
conversion
of
listed
options
exercisable at $1.10 on or before 31
May 2018
Yes
  • the date from which they do

  • the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment

  • the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment

  • 5 Issue price or consideration $1.10 each 6 Purpose of the issue Exercise of listed options (If issued as consideration for the acquisition of assets, clearly identify those assets)

6a Is the entity an[+] eligible Yes entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security holder 10 May 2017 resolution under rule 7.1A was passed 6c Number of +securities N/A issued without security holder approval under rule 7.1 6d Number of +securities N/A issued with security holder approval under rule 7.1A 6e Number of +securities N/A issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of +securities 30,000 issued under exception 4 issued under an exception in rule 7.2 6g If[+] securities issued under N/A rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation.

  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 3

6h If[+] securities were issued N/A under rule 7.1A for noncash consideration, state date on which valuation of consideration was released to ASX Market Announcements

6i Calculate the entity’s 7.1: 10,686,544 remaining issue capacity under rule 7.1 and rule 7.1A: 7,124,363 7.1A – complete Annexure 1 and release to ASX Market Announcements

7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B.

12 January 2018

Number +Class 8 Number and[+] class of all 71,243,632 Fully Paid +securities quoted on ASX Ordinary Shares (including the[+] securities in section 2 if applicable) 63,912,406 Options exercisable at $1.10 on or before 31 May 2018

  • Number +Class

  • 9 Number and[+] class of all +securities not quoted on ASX (including the +securities in section 2 if applicable)

10 Dividend policy (in the case Same as existing. of a trust, distribution policy) on the increased capital (interests)

Part 2 - Pro rata issue

11
Is security holder approval
required?
12
Is the issue renounceable or
non-renounceable?
13
Ratio
in
which
the
+securities will be offered
14
+Class
of
+securities
to
which the offer relates
15
+Record date to determine
entitlements
16
Will holdings on different
registers (or subregisters)
be
aggregated
for
calculating entitlements?
17
Policy
for
deciding
entitlements in relation to
fractions
18
Names of countries in which
the
entity
has
security
holders who will not be sent
new offer documents
Note: Security holders must be told how
their entitlements are to be dealt with.
Cross reference: rule 7.7.
19
Closing date for receipt of
acceptances
or
renunciations
20
Names of any underwriters
21
Amount of any underwriting
fee or commission
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 5

22
Names of any brokers to the
issue
23
Fee or commission payable
to the broker to the issue
24
Amount of any handling fee
payable
to
brokers
who
lodge
acceptances
or
renunciations on behalf of
security holders
25
If the issue is contingent on
security holders’ approval,
the date of the meeting
26
Date
entitlement
and
acceptance form and offer
documents will be sent to
persons entitled
27
If the entity has issued
options,
and
the
terms
entitle
option
holders
to
participate on exercise, the
date on which notices will be
sent to option holders
28
Date rights trading will begin
(if applicable)
29
Date rights trading will end
(if applicable)
30
How do security holders sell
their
entitlements
in
full
through a broker?
31
How do security holders sell
part of their entitlements
through a broker and accept
for the balance?
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
  • 32 How do security holders dispose of their entitlements

N/A

(except by sale through a

broker)?

33 +Issue date

N/A

Part 3 - Quotation of securities

You need only complete this section if you are applying for quotation of securities

  • 34 Type of[+] securities (tick one)

  • (a) +Securities described in Part 1

(b)[All other ][+][securities ]

Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities

Entities that have ticked box 34(a)

Additional securities forming a new class of securities

Tick to indicate you are providing the information or documents

  • 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders

  • 36 If the[+] securities are[+] equity securities, a distribution schedule of the additional[+] securities setting out the number of holders in the categories

1 - 1,000

  • 1,001 - 5,000

5,001 - 10,000

10,001 - 100,000

100,001 and over

  • 37 A copy of any trust deed for the additional[+] securities

  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 7

Entities that have ticked box 34(b)

38
Number of+securities for
which+quotation is sought
39
+Class
of
+securities
for
which quotation is sought
40
Do
the
+securities
rank
equally in all respects from
the
+issue
date
with
an
existing
+class of quoted
+securities?
If the additional+securities
do not rank equally, please
state:

the date from which they do

the extent to which they
participate
for
the
next
dividend, (in the case of a
trust, distribution) or interest
payment
 the extent to which they do
not rank equally, other than
in
relation
to
the
next
dividend,
distribution
or
interest payment
41
Reason
for
request
for
quotation now
Example: In the case of
restricted securities, end of
restriction period
(if issued upon conversion of
another
+security,
clearly
identify that other+security)
42
Number and+class of all
+securities quoted on ASX
(including the+securities in
clause 38)
N/A
N/A
N/A
N/A
Number +Class
N/A

Quotation agreement

  • 1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.

2 We warrant the following to ASX.

  • The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.

  • There is no reason why those[+] securities should not be granted +quotation.

  • An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.

Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty

  • Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.

  • If we are a trust, we warrant that no person has the right to return the[+] securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.

  • 3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.

  • 4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before[+] quotation of the[+] securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.

Sign here:

==> picture [157 x 40] intentionally omitted <==

Date: 15 January 2018

Print name: Donald Stephens (Company secretary)

== == == == ==

  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 9

Appendix 3B – Annexure 1

Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities

Introduced 01/08/12 Amended 04/03/13

Part 1

Rule 7.1 – Issues exceeding 15% of capital Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

  • Insert number of fully paid[+] ordinary 63,965,406 securities on issue 12 months before the + issue date or date of agreement to issue Add the following: • Number of fully paid[+] ordinary securities 3,000 issued on 16/08/2017 issued in that 12 month period under an exception in rule 7.2 615,226 issued on 16/11/2017 10,000 issued on 14/12/2017 6,610,000 issued on 13/11/2017 10,000 issued on 22/12/2017 30,000 issued on 12/01/2018

  • • Number of fully paid[+] ordinary securities issued in that 12 month period with shareholder approval

  • • Number of partly paid[+] ordinary securities that became fully paid in that 12 month period

  • Note: • Include only ordinary securities here – other classes of equity securities cannot be added

  • • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed

  • • It may be useful to set out issues of securities on different dates as separate line items

  • Subtract the number of fully paid[+] ordinary nil securities cancelled during that 12 month period “A” 71,243,632

Step 2: Calculate 15% of “A”

Step 2: Calculate 15% of “A” Step 2: Calculate 15% of “A”
“B” 0.15
[Note: this value cannot be changed]
Multiply“A” by 0.15 10,686,544
Step 3: Calculate “C”, the amount of placement capacity under rule
7.1 that has already been used
Insertnumber of+equity securities issued
or agreed to be issued in that 12 month
period_not counting_those issued:
• Under an exception in rule 7.2
• Under rule 7.1A
• With security holder approval under rule
7.1 or rule 7.4
Note:
• This applies to equity securities, unless
specifically excluded – not just ordinary
securities
• Include here (if applicable) the securities
the subject of the Appendix 3B to which
this form is annexed
• It may be useful to set out issues of
securities on different dates as separate
line items
nil
“C” nil
Step 4: Subtract “C” from [“A” x “B”] to calculate remaining
placement capacity under rule 7.1
“A” x 0.15
Note: number must be same as shown in
Step 2
10,686,544
Subtract“C”
Note: number must be same as shown in
Step 3
nil
Total[“A” x 0.15] – “C” 10,686,544
[Note: this is the remaining placement
capacity under rule 7.1]
  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 11

Part 2

Rule 7.1A – Additional placement capacity for eligible entities

Step 1: Calculate “A”, the base figure from which the placement capacity is calculated

“A” 71,243,632 Note: number must be same as shown in Step 1 of Part 1

Step 2: Calculate 10% of “A”

“D”

0.10

Multiply “A” by 0.10

Note: this value cannot be changed 7,124,363

Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used

Insert number of[+] equity securities issued or agreed to be issued in that 12 month period under rule 7.1A

nil

Notes:

  • This applies to equity securities – not just ordinary securities

  • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed

  • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained

  • It may be useful to set out issues of securities on different dates as separate line items

“E” nil

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A

Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining
placement capacity under rule 7.1A
“A” x 0.10
Note: number must be same as shown in
Step 2
7,124,363
Subtract“E”
Note: number must be same as shown in
Step 3
nil
Total[“A” x 0.10] – “E” 7,124,363
Note: this is the remaining placement
capacity under rule 7.1A
  • See chapter 19 for defined terms.

04/03/2013

Appendix 3B Page 13